Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae. | J Antimicrob Chemother;41(3): 367-72, 1998 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.

Mimoz, O; Jacolot, A; Padoin, C; Tod, M; Samii, K; Petitjean, O.

Affiliation

Mimoz O; Service d'Anesthésie-Réanimation Chirurgicale, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. darkb@imaginet.fr

J Antimicrob Chemother ; 41(3): 367-72, 1998 Mar.

Article in En | MEDLINE | ID: mdl-9578163

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Amikacin / Cephalosporins / Enterobacter cloacae / Cephalosporin Resistance / Enterobacteriaceae Infections / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Antimicrob Chemother Year: 1998 Document type: Article Affiliation country: Francia

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Amikacin / Cephalosporins / Enterobacter cloacae / Cephalosporin Resistance / Enterobacteriaceae Infections / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Antimicrob Chemother Year: 1998 Document type: Article Affiliation country: Francia